(Información remitida por la empresa firmante)
[1] Protofibrils are large Aß aggregated soluble species of 75-5000 Kd[2] Mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD dementia
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/marketing-authorisation-application-for-lecanemab-submitted-in-great-britain-bioarctic-301830416.html